Senate vote looms for FDA pick: 3 federal leadership updates 

Advertisement

President Donald Trump’s administration is reshaping leadership across several federal agencies that oversee healthcare research, spending and regulation.

The NIH named a permanent director for its infectious disease institute, and the president tapped a new nominee to lead the Government Accountability Office, which audits federal health agencies and appoints members to the commissions that advise Congress on Medicare and Medicaid payment. Meanwhile, the administration’s pick for FDA commissioner faces a Senate committee vote Nov. 18 amid reports that officials have discussed abandoning the nomination.

Here are six things to know about the leadership moves:

NIAID

1. John Powers III, MD, was named director of the NIH’s National Institute of Allergy and Infectious Diseases after leading the institute on an acting basis since June. He will oversee NIAID’s $6.56 billion annual budget and carry out the research agenda in its new strategic plan.

2. Dr. Powers has more than three decades of experience in clinical medicine, infectious diseases research and clinical trial design, according to a Nov. 16 NIH news release. His work has focused on making sure studies measure outcomes that matter to patients, such as survival, function, symptoms and quality of life. NIH Director Jay Bhattacharya, MD, PhD, said Dr. Powers will bring “a focus on rigor, transparency, and research outcomes” to the institute.

Comptroller general

3. President Trump tapped Eric Ueland to be comptroller general, sending the nomination to the Senate on Nov. 16. If confirmed, Mr. Ueland would serve a 15-year term as head of the Government Accountability Office, the federal watchdog that audits government spending, including at HHS, CMS and the FDA. The comptroller general is required to appoint members to several healthcare bodies, including the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission, whose recommendations shape how Congress sets Medicare and Medicaid payment rates for hospitals and physicians.

4. Mr. Ueland has served as deputy director for management at the Office of Management and Budget since May 2025 and has been performing the duties of controller since September 2025, according to his LinkedIn profile. Before joining the OMB in January 2025 as acting chief of staff, he was deputy administrator of USAID.

FDA commissioner

5. The Senate Health, Education, Labor and Pensions Committee will vote Nov. 18 on President Trump’s nominee for FDA commissioner, Heidi Overton, MD, PhD. President Trump announced the nomination Aug. 19. Dr. Overton serves as deputy assistant to the president for domestic policy at the White House, where she works on health issues.

6. In a Sept. 30 letter, a coalition of more than 2,500 physicians urged the Senate to reject the nomination, citing Dr. Overton’s role in the administration’s efforts to change childhood vaccination policy and her previous writing opposing telehealth access to medication abortion. Some administration officials have discussed abandoning the nomination amid growing doubts that the Senate will confirm her, The Washington Post reported Nov. 16, citing four people familiar with the matter.

Advertisement

Next Up in Leadership & Management

Advertisement